Accelerate Diagnostics Achieves ISO 13485 Certification and Initial Installations of Accelerate ID/AST System
16 mars 2015 14h15 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., March 16, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic...
Accelerate Diagnostics to Present at the Cowen and Company 35th Annual Health Care Conference on March 4, 2015
25 févr. 2015 05h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Feb. 25, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
Accelerate Diagnostics to Present at the 33rd Annual J.P. Morgan Healthcare Conference
07 janv. 2015 05h30 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...
Accelerate Diagnostics Announces Research Collaboration With CDC Laboratory for Early Detection of Antibiotic-Resistant Biothreat Agents
03 nov. 2014 13h50 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant...
Accelerate Diagnostics Supports Drug Stewardship and Early Detection in the President's Initiative to Combat Antibiotic-Resistant Bacteria
25 sept. 2014 14h35 HE
|
Accelerate Diagnostics, Inc.
TUCSON, Ariz., Sept. 25, 2014 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (Nasdaq:AXDX), an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug...